Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.

This study is recruiting in France. It is testing compassion Focused Therapy for Bipolarity; Schizophrenia; Depression; Borderline Personality Disorder; Autism Spectrum Disorder.
Leave your email and HopeStage can help you better understand this study.
This study is looking at whether cognitive behavioural therapy can help people with depression, psychosis, or bipolarity. Participants take part in cognitive behavioural therapy and complete follow-up assessments. Taking part may give some people access to cognitive behavioural therapy, but direct benefit is not guaranteed.
The official record suggests in-person participation through a hospital, with sites including Pôle de Psychiatrie Adulte, Hôpital Charles Perrens in Bordeaux, Ch Le Vinatier in Bron, and CHU de Clermont-Ferrand, Hôpital Gabriel Montpied, Service de Psychiatrie B in Clermont-Ferrand. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually matching the main diagnosis and meeting the main study requirements, while common reasons not to take part include active substance or alcohol problems that could affect the results and other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This study may matter because it is evaluating Compassion Focused Therapy, Ending Self Stigma in a structured research setting. For people exploring bipolarity research, clear information about the goal, status, contacts, and official source can support better questions before any decision.
Taking part may help test a support approach in real life.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in France.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring psychotherapy or therapy for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by University Hospital, Strasbourg, France. Based on the sponsor name or official registry information, it appears to be a hospital or academic medical center. You should verify the details in the official registry record.
This study may involve psychotherapy or therapy, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me